Diagnostic Imaging: Clinical Trials

3 trials for Diagnostic Imaging, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed. 3 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 33Completed 3

Follow Diagnostic Imaging: new trials by email Literature Review of Diagnostic Imaging trials Research Report on Diagnostic Imaging

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Efficacy and Safety of Gadobutrol 1.0 Molar (Gadovist) for Breast MRI
Gadobutrol (Gadavist, Gadovist, BAY86-4875) - Breast Cancer, Diagnostic Imaging
Phase 3CompletedBayer4462010-02-012014-11-11
Safety and Efficacy of Gadobutrol 1.0 Molar (Gadavist) in Patients for Central Nervous System (CNS) Imaging
Gadobutrol (Gadavist, Gadovist, BAY86-4875), Gadoteridol (ProHance) - Diagnostic Imaging, Central Nervous System Diseases
Phase 3CompletedBayer4022008-06-012014-12-30
Ultravist: Safety and Efficacy in Computed Tomography of Head and Body
Iopromide 370 mg I/mL, Iopromide 300 mg I/mL - Computed Tomography, Diagnostic Imaging
Phase 3CompletedBayer4352005-10-012014-02-28

Narrower conditions

Breast Neoplasms (1)  ·  Central Nervous System Diseases (1)

Broader conditions

Breast Diseases (1)  ·  Neoplasms (1)  ·  Neoplasms by Site (1)  ·  Nervous System Diseases (1)  ·  Skin Diseases (1)  ·  Skin and Connective Tissue Diseases (1)

Interventions

gadobutrol (2)  ·  gadoteridol (1)  ·  iopromide (1)

Sponsors

Bayer (3)

Countries

Colombia (3)  ·  United States (3)  ·  Germany (2)  ·  India (2)  ·  South Korea (2)  ·  Switzerland (2)  ·  Argentina (1)  ·  Australia (1)  ·  Austria (1)  ·  Brazil (1)  ·  Finland (1)  ·  Italy (1)  ·  Japan (1)

Results publications

PMID 26840494, PMID 35462754

NIH funding

2009 (1)